Sun Pharma shares down nearly 3 pc as Q3 profit declines

Image
Press Trust of India Mumbai
Last Updated : Feb 16 2015 | 6:45 PM IST
Shares of drug major Sun Pharma today fell by nearly 3 per cent after the company reported 6.92 per cent decline in consolidated net profit for the third quarter ended December 31, 2014-15.
The stock slipped 2.65 per cent to settle at Rs 914.50 on the BSE. During the day, it lost 3.32 per cent to Rs 908.10.
At the NSE, it fell by 2.83 per cent to close at Rs 913.90.
The stock was the biggest loser among the blue-chip scrips on both Sensex and Nifty.
In terms of volume, 2.17 lakh shares were traded at the BSE, while over 28 lakh shares changed hands at the NSE during the day.
Drug major Sun Pharma had on Saturday reported 6.92 per cent decline in consolidated net profit at Rs 1,425.07 crore for the third quarter ended December 31, 2014-15, saying it was hit by supply constraints.
The company had posted a net profit of Rs 1,531.09 crore for the October-December period of the previous fiscal.
Net sales of the company declined to Rs 4,279.54 crore for the quarter under consideration, as against Rs 4,286.59 crore during the same period of 2013-14, Sun Pharmaceutical Industries had said in a statement.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 16 2015 | 6:45 PM IST

Next Story